Deutsche Bank’s Upstream Bio Inc UPB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$152K Sell
28,891
-212,556
-88% -$1.39M ﹤0.01% 3224
2026
Q2
$1.67M Buy
241,447
+60,558
+33% +$507K ﹤0.01% 2005
2026
Q1
$1.63M Buy
180,889
+53,074
+42% +$955K ﹤0.01% 1887
2025
Q4
$3.47M Buy
127,815
+101,078
+378% +$2.52M ﹤0.01% 1494
2025
Q3
$503K Buy
26,737
+3,334
+14% +$51.8K ﹤0.01% 2536
2025
Q2
$257K Buy
23,403
+8,211
+54% +$75.8K ﹤0.01% 2826
2025
Q1
$93K Buy
15,192
+341
+2% +$3.26K ﹤0.01% 3222
2024
Q4
$244K Buy
+14,851
New +$332K ﹤0.01% 3008

Other funds holding UPB

Deutsche Bank's UPB Position: Q3 2026 in Review

Deutsche Bank reduced its Upstream Bio Inc (UPB) stake by 88% in Q3 2026, selling an estimated $1.39M and leaving 28,891 shares worth $152K. The position accounts for ﹤0.01% of the portfolio, ranked #3224.

Deutsche Bank first reported a position in UPB in Q4 2024 and has held it in 8 quarters since. The position peaked at $3.47M in Q4 2025. 50 funds tracked by Wall St. Rank hold UPB as of Q3 2026.

  • Deutsche Bank held 28,891 shares of Upstream Bio Inc worth $152K as of Q3 2026.
  • Deutsche Bank sold 212,556 Upstream Bio Inc shares in Q3 2026, an estimated $1.39M.
  • Upstream Bio Inc made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #3224 holding.
  • Deutsche Bank first reported a position in Upstream Bio Inc in Q4 2024 and has held it in 8 quarters since.
  • Deutsche Bank's Upstream Bio Inc position peaked at $3.47M in Q4 2025.
  • 50 funds tracked by Wall St. Rank held Upstream Bio Inc as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.